Typo Errors, Colour Mismatch Lead to Bust of Fake Mounjaro in Gurugram Written By sheeba farhat24 April 2026 10:45 AM ISTGurugram: Colour dissimilarity to typographical errors, conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs...
Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets Written By sheeba farhat16 April 2026 8:30 PM ISTHyderabad: Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 million pens of generic weight-loss and diabetes drugs in...
Doctors raise alarm over misuse of GLP 1 weight loss drugs, demand restrictions on unqualified prescribing Written By Anshika Mishra26 March 2026 6:15 PM ISTSince several generic variants of GLP-1- based weight loss drugs have entered the Indian Market and the government has tightened surveillance against...
Health Bulletin 26/March/2026 Written By Anshika Mishra26 March 2026 5:56 PM ISTHere are the top health stories for the day:MBBS Seats in India Rise to 1,28,976 From 51,348 Since 2013, MoS Health Informs ParliamentThe Union...
Doctors raise alarm over misuse of GLP 1 weight loss drugs, seek curbs on unqualified prescribing Written By Adity Saha25 March 2026 9:30 AM ISTNew Delhi: Since several generic variants of GLP-1- based weight loss drugs have entered the Indian Market and the government has tightened...
DCGI Orders Audits, Steps Up Action on GLP-1 Weight Loss Drugs Misuse and Marketing Written By Parthika Patel24 March 2026 6:15 PM ISTNew Delhi: In order to ensure ethical pharmaceutical practices in the supply chain of Weight Loss Drug (GLP-1), the Drugs Controller of India has...
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply Written By sheeba farhat20 March 2026 11:13 PM ISTHyderabad: India's market for diabetes and weight-loss drugs is set for a shake-up as Danish drugmaker Novo Nordisk's patent on semaglutide expires...
7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Written By Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning Written By sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound Written By sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts Written By sheeba farhat9 Jan 2026 11:28 PM ISTBengaluru: Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic,...
GLP-1 Drugs Linked to Lower Cataract and Dry AMD Risk: Study Written By Dr Riya Dave15 Dec 2025 9:00 PM ISTRecent studies show that GLP-1 receptor agonists are associated with a significantly reduced risk of age-related cataracts and a lower risk of...
